New Advances in Allergen Immunotherapy
Saturday, February 21, 2015: 10:45 AM-12:00 PM
Convention Center, Level Three, General Assembly Theater C
1.25 CME/ 1.50 CE
Michael S. Tankersley , MD FAAAAI

Learning Objectives

  1. Determine how to best evaluate immunotherapy outcomes
  2. Evaluate and discuss new research findings of immunotherapy with modified molecules and adjuvants, and how these modifications might enhance efficacy and safety of immunotherapy in the future
  3. Recognize and discuss the immunoregulatory function of certain epitopes: how they were discovered, their mechanisms of action and what their role might be in immunotherapy
10:45 AM
What Constitutes Clinically Meaningful Effect: Findings from Recent Clinical Trials with Sublingual Immunotherapy
Peter S. Creticos, MD FAAAAI
11:05 AM
Modified Allergens, Adjuvants and New Constructs: Where Do We Stand?
Rudolf Valenta, MD
11:25 AM
Synthetic Peptide Immunoregulatory Epitopes
Stephen R. Durham, MD MA
11:45 AM
Question & Answer
See more of: Symposia